scholarly journals Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and neuropsychiatric symptoms in elderly patients with dementia

Author(s):  
Tom Declercq ◽  
Mirko Petrovic ◽  
Robert Vander Stichele ◽  
An IM De Sutter ◽  
Mieke L van Driel ◽  
...  
2020 ◽  
Vol 30 (2) ◽  
pp. 81-86
Author(s):  
Soo Mi Yoon ◽  
Sungwon Lee ◽  
Ji-Eun Chang ◽  
Young Sook Lee ◽  
Kiyon Rhew

2007 ◽  
Vol 25 (2) ◽  
pp. 103-108 ◽  
Author(s):  
Manuel Fernández Martínez ◽  
Jéssica Castro Flores ◽  
Susana Pérez de las Heras ◽  
Aitxiber Mandaluniz Lekumberri ◽  
María Gordejuela Menocal ◽  
...  

2013 ◽  
Vol 28 ◽  
pp. 1
Author(s):  
H. Ben Ammar ◽  
A. Bel Arbi ◽  
L. Robbana ◽  
O. Moula ◽  
A. Bouasker ◽  
...  

2008 ◽  
Vol 8 (8) ◽  
pp. 776-783 ◽  
Author(s):  
Sara Mazzucco ◽  
Andrea Cipriani ◽  
Corrado Barbui ◽  
Salvatore Monaco

2019 ◽  
Author(s):  
Ehud Mekori-Domachevsky ◽  
Yuval Nash ◽  
Alon Rabinovich ◽  
Dan Frenkel ◽  
Yvonne Freund-Levi

Abstract Background: Antipsychotic drugs are commonly used for various neuropsychiatric disorders, such as psychotic disorders, mood disorders, and neuropsychiatric symptoms in dementia. Their mechanism of action is thought to be by modulation of neurotransmitter activity in the brain, mainly dopamine. It has been suggested that antipsychotic drugs may also exert anti-inflammatory properties. This study aimed to examine whether the modulating effect of antipsychotic drugs on neurotransmitters attenuates the inflammatory response of microglia cells. Methods: Levels of interleukin 6 (IL-6) were measured following activation of microglia cultures with lipopolysaccharides and treatment with antipsychotic drugs (risperidone, haloperidol, and clozapine), neurotransmitters (dopamine, serotonin, and acetylcholine), or a combination of dopamine and either haloperidol or clozapine. Results: Haloperidol and clozapine decreased IL-6 secretion by microglia cells when treated at a concentration of 10-5M. Interestingly, dopamine at a concentration of 1 μM increased IL-6 secretion by the microglia cells, while a concentration of 100 μM decreased it. The combination of dopamine (from 0.001 μM to 100 μM) with either haloperidol (10-5M or 10-8M) or clozapine (10-5M or 10-7M) attenuated IL-6 secretion in a bell-shaped curve with a peak at 1 μM. High concentrations of both haloperidol and clozapine decreased IL-6 secretion, while low concentrations modestly increased IL-6 levels. Conclusions: Our findings support anti-inflammatory properties of antipsychotic drugs, and suggest that their action is mediated via the inhibition of dopaminergic activity in microglia cells. The bell-shaped curve of IL-6 secretion by microglia might suggest the presence of an “optimal zone” of operation for these cells that is mediated by dopamine.


2016 ◽  
Vol 8 (1) ◽  
pp. 40-46
Author(s):  
Yoshihiro Tominaga ◽  
Manabu Okada ◽  
Takayuki Yamamoto ◽  
Takahisa Hiramitsu

ABSTRACT BACKGROUND AND AIMS The number of elderly patients with primary hyperparathyroidism (PHPT) has been increasing as a result of declining birth rate and aging population in Japan. The safety and effectiveness of surgical treatment in old people with PHPT are still contentious. METHODS We retrospectively investigated the characteristics and postoperative course in 55 patients over 70 years of age who underwent parathyroidectomy (PTX) for PHPT at our institution from February 1988 to May 2015. RESULTS Forty-four of the 55 patients had comorbidities such as hypertension, diabetes, and so on. In all the cases, PTX was successfully performed and the serum levels of parathyroid hormone and calcium lowered. Neuropsychiatric symptoms also improved in 14 patients after PTX. Except two cases, no severe complication occurred after PTX: one developed aspiration pneumonitis and one needed hemodialysis for acute exacerbation in chronic kidney disease. CONCLUSION Active and appropriate application of PTX might contribute to improvements in the activities of daily living and quality of life in elderly patients with PHPT.


2016 ◽  
Vol 10 (3) ◽  
pp. 178-184 ◽  
Author(s):  
Raiana Lídice Mór Fukushima ◽  
Elisangela Gisele do Carmo ◽  
Renata do Valle Pedroso ◽  
Pollyanna Natalia Micali ◽  
Paula Secomandi Donadelli ◽  
...  

ABSTRACT Introduction: Neuropsychiatric symptoms are frequent in Alzheimer's disease and negatively affect patient quality of life. Objective: To assess the effectiveness of cognitive stimulation on neuropsychiatric symptoms in elderly patients with Alzheimer's disease. Methods: The included articles were reviewed between December 2015 and June 2016, and the inclusion criteria were: (1) studies involving older adults diagnosed with Alzheimer's disease; (2) studies published in English, Spanish or Portuguese; (3) studies that determined the effect of cognitive stimulation on neuropsychiatric symptoms in elderly patients with Alzheimer's disease; (4) controlled trials. Results: Out of the total 722, 9 articles matched the inclusion criteria. Depression, apathy and anxiety were the most frequent symptoms. Conclusion: Studies reported significant results post-treatment, suggesting cognitive stimulation can be effective for these neuropsychiatric symptoms, thus improving the quality of life of Alzheimer's disease patients and their caregivers.


2016 ◽  
Vol 33 (S1) ◽  
pp. S190-S190 ◽  
Author(s):  
P. Sá Esteves ◽  
D. Loureiro ◽  
E. Albuquerque ◽  
F. Vieira ◽  
L. Lagarto ◽  
...  

IntroductionDementia is one of the leading causes of disability and burden in Western countries. In Portugal, there is a lack of data regarding dementia prevalence in hospitalized elderly patients and factors associated with in-hospital adverse outcomes of these patients.ObjectivesDetermine dementia prevalence in acutely-ill medical hospitalized elderly patients and its impact in health outcomes.MethodsAll male patients (> 65 years) admitted to a medical ward (> 48 h) between 1.03.2015 to 31.08.2015 were included in the study. Patients were excluded if unable to be assessed due to sensorial deficits, communication problems or severity of the acute medical condition. Baseline evaluation included socio-demographic variables, RASS, NPI, Barthel Index and Confusion Assessment Method.ResultsThe final sample consisted of 270 male subjects with a mean age of 80.9 years, 116 (43%) having prior dementia. Dementia patients were significantly older (83.5 vs 78.9; P < 0.001) and had lower values of Barthel Index (dementia: 34.8 vs non-dementia: 85.8; P < 0.001). Mortality rate (9,3%) and length of hospitalization (11.2 days) were similar between groups (12.1 vs 7.1; P = 0.204 and 11.9 vs 10.6; P = 0.218, respectively). Patients with dementia had higher rates of all neuropsychiatric symptoms except depression, anxiety and mood elation. The level of consciousness (measured by RASS) was impaired in 50% of patients with dementia, which was significantly higher than in non-demented subjects (12.3%; P < 0.001). Delirium rates were 29.5% in dementia compared with 7.1% in controls (P < 0.001).ConclusionsThere is a high prevalence of dementia and an appreciable rate of delirium among these patients.Disclosure of interestThe authors have not supplied their declaration of competing interest.


Sign in / Sign up

Export Citation Format

Share Document